Search research articles
Contact Us
Filters
Showing results (41-50 of 78) with videos related to
Page
of 8
Sort By:
Breast Cancer (Tokyo, Japan)
|
April 10, 2024
Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases
Alexandre De Moura, Delphine Loirat, Sarah Vaillant, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 22, 2023
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab
Romain-David Seban, Emilie Arnaud, Delphine Loirat, et al.
Fundamental & Clinical Pharmacology
|
October 22, 2017
Drug monitoring of sunitinib in patients with advanced solid tumors: a monocentric observational French study
Luc Cabel, Benoit Blanchet, Audrey Thomas-Schoemann, et al.
Scientific Reports
|
November 7, 2025
Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie Hospitals
Alexandre De Moura, Orane Gleizes, Luc Cabel, et al.
Cancers
|
March 24, 2019
Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients
Luc Cabel, Charles Decraene, Ivan Bieche, et al.
JCO Precision Oncology
|
February 9, 2022
<i>ERBB3</i>-Activating Mutations in Small Bowel Adenocarcinomas
Luc Cabel, Thomas Aparicio, Ivan Bieche, et al.
Oncogene
|
February 27, 2024
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis
Antoine Vasseur, Luc Cabel, Caroline Hego, et al.
Breast Cancer Research : BCR
|
March 7, 2021
Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients
Lauren Darrigues, Jean-Yves Pierga, Alice Bernard-Tessier, et al.
Breast Cancer Research : BCR
|
May 29, 2020
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
Perrine Vuagnat, Maxime Frelaut, Toulsie Ramtohul, et al.
Oncogene
|
February 12, 2020
A single droplet digital PCR for ESR1 activating mutations detection in plasma
Emmanuelle Jeannot, Lauren Darrigues, Marc Michel, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 78) with videos related to
Sort By:
Page
of 8
Breast Cancer (Tokyo, Japan)
|
April 10, 2024
Sacituzumab govitecan in metastatic triple-negative breast cancer patients treated at Institut Curie Hospitals: efficacy, safety, and impact of brain metastases
Alexandre De Moura, Delphine Loirat, Sarah Vaillant, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
August 22, 2023
[18F]FDG PET/CT for predicting triple-negative breast cancer outcomes after neoadjuvant chemotherapy with or without pembrolizumab
Romain-David Seban, Emilie Arnaud, Delphine Loirat, et al.
Fundamental & Clinical Pharmacology
|
October 22, 2017
Drug monitoring of sunitinib in patients with advanced solid tumors: a monocentric observational French study
Luc Cabel, Benoit Blanchet, Audrey Thomas-Schoemann, et al.
Scientific Reports
|
November 7, 2025
Efficacy and toxicity of post-neoadjuvant trastuzumab emtansine in HER2-positive breast cancer patients treated at Institut Curie Hospitals
Alexandre De Moura, Orane Gleizes, Luc Cabel, et al.
Cancers
|
March 24, 2019
Limited Sensitivity of Circulating Tumor DNA Detection by Droplet Digital PCR in Non-Metastatic Operable Gastric Cancer Patients
Luc Cabel, Charles Decraene, Ivan Bieche, et al.
JCO Precision Oncology
|
February 9, 2022
<i>ERBB3</i>-Activating Mutations in Small Bowel Adenocarcinomas
Luc Cabel, Thomas Aparicio, Ivan Bieche, et al.
Oncogene
|
February 27, 2024
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis
Antoine Vasseur, Luc Cabel, Caroline Hego, et al.
Breast Cancer Research : BCR
|
March 7, 2021
Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients
Lauren Darrigues, Jean-Yves Pierga, Alice Bernard-Tessier, et al.
Breast Cancer Research : BCR
|
May 29, 2020
COVID-19 in breast cancer patients: a cohort at the Institut Curie hospitals in the Paris area
Perrine Vuagnat, Maxime Frelaut, Toulsie Ramtohul, et al.
Oncogene
|
February 12, 2020
A single droplet digital PCR for ESR1 activating mutations detection in plasma
Emmanuelle Jeannot, Lauren Darrigues, Marc Michel, et al.
Page
of 8